Reply to the article "The significance of skeletal-related events for the health-related quality of life of patients with metastatic prostate cancer" by K. P.!Weinfurt et al. (Ann Oncol 2005; 16: 579-584)

被引：0
|
作者：
Bouché, O [1 ]
Brixi-Benmansour, H [1 ]
Bertin, A [1 ]
Perceau, G [1 ]
Lagarde, S [1 ]
机构：
[1] Loyola Univ, Stritch Sch Med, Maywood, IL 60153 USA
来源：
ANNALS OF ONCOLOGY | 2005年 / 16卷 / 10期
关键词：
D O I：
10.1093/annonc/mdi301
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1712 / 1713
页数：2
相关论文
共 10 条
  • [1] The significance of skeletal-related events for the health-related quality of life of patients with metastatic prostate cancer
    Weinfurt, KP
    Li, Y
    Castel, LD
    Saad, F
    Timbie, JW
    Glendenning, GA
    Schulman, KA
    ANNALS OF ONCOLOGY, 2005, 16 (04) : 579 - 584
  • [2] The impact of skeletal-related events on preferences and health-related quality of life of patients with metastatic prostate cancer
    Weinfurt, KP
    Castel, LD
    Li, Y
    Saad, F
    Timbie, JW
    Glendenning, A
    Schulman, KA
    JOURNAL OF UROLOGY, 2004, 171 (04): : 42 - 42
  • [3] Assessing health-related quality of life in patients with breast cancer: a reply to Ribi et al.
    Stefano Maratia
    Sergio Cedillo
    Javier Rejas
    Quality of Life Research, 2018, 27 : 2757 - 2758
  • [4] Assessing health-related quality of life in patients with breast cancer: a reply to Ribi et al.
    Maratia, Stefano
    Cedillo, Sergio
    Rejas, Javier
    QUALITY OF LIFE RESEARCH, 2018, 27 (10) : 2757 - 2758
  • [5] Skeletal-related events significantly impact health-related quality of life in metastatic castration-resistant prostate cancer: data from PREVAIL and AFFIRM trials
    Saad, F.
    Ivanescu, C.
    Phung, D.
    Loriot, Y.
    Abhyankar, S.
    Beer, T. M.
    Tombal, B.
    Holmstrom, S.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2017, 20 (01) : 110 - 116
  • [6] Skeletal-related events significantly impact health-related quality of life in metastatic castration-resistant prostate cancer: data from PREVAIL and AFFIRM trials
    F Saad
    C Ivanescu
    D Phung
    Y Loriot
    S Abhyankar
    T M Beer
    B Tombal
    S Holmstrom
    Prostate Cancer and Prostatic Diseases, 2017, 20 : 110 - 116
  • [7] SKELETAL-RELATED EVENTS HAVE A SIGNIFICANT IMPACT ON HEALTH-RELATED QUALITY OF LIFE IN MEN WITH METASTATIC CASTRATION RESISTANT PROSTATE CANCER (MCRPC) FOLLOWING DOCETAXEL THERAPY FAILURE
    Ivanescu, C.
    Phung, D.
    Holmstrom, S.
    VALUE IN HEALTH, 2013, 16 (07) : A392 - A392
  • [8] SKELETAL-RELATED EVENTS (SRES) IMPACT SIGNIFICANTLY THE HEALTH-RELATED QUALITY OF LIFE (HRQOL) OF CHEMO-NAIVE MEN WITH METASTATIC CASTRATION RESISTANT PROSTATE CANCER (MCRPC)
    Ivanescu, C.
    Phung, D.
    Loriot, Y.
    Saad, F.
    Mansbach, H.
    Beer, T. M.
    Tombal, B.
    Holmstrom, S.
    VALUE IN HEALTH, 2014, 17 (07) : A650 - A651
  • [9] Effect of enzalutamide on health-related quality of life, pain, and skeletal-related events in asymptomatic and minimally symptomatic, chemotherapy-naive patients with metastatic castration-resistant prostate cancer (PREVAIL): results from a randomised, phase 3 trial
    Loriot, Yohann
    Miller, Kurt
    Sternberg, Cora N.
    Fizazi, Karim
    De Bono, Johann S.
    Chowdhury, Simon
    Higano, Celestia S.
    Noonberg, Sarah
    Holmstrom, Stefan
    Mansbach, Harry
    Perabo, Frank G.
    Phung, De
    Ivanescu, Cristina
    Skaltsa, Konstantina
    Beer, Tomasz M.
    Tombal, Bertrand
    LANCET ONCOLOGY, 2015, 16 (05): : 509 - 521
  • [10] Symptomatic skeletal events, health-related quality of life and pain in a phase III study of [177Lu]Lu-PSMA-617 in taxane-naive patients with PSMA-positive metastatic castration-resistant prostate cancer: Third interim analysis of PSMAfore
    Fizazi, K.
    Morris, M. J.
    Shore, N. D.
    Chi, K. N.
    Crosby, M.
    de Bono, J. S.
    Herrmann, K.
    Roubaud, G.
    Nagarajah, J.
    Fleming, M. T.
    Lewis, B.
    Nordquist, L. T.
    Castellano Gauna, D. E.
    Carnahan, N.
    Ghebremariam, S.
    Hertelendi, M.
    Sartor, O.
    ANNALS OF ONCOLOGY, 2024, 35 : S964 - S965
1